Presenter: Richard Gallo, MD, PhD is an Irma Gigli Distinguished Professor and the Chairman of the Department of Dermatology at the University of California San Diego.
This activity was supported with an educational grant from Galderma.
Special thanks to Sanofi Genzyme and Regeneron for their support of this event.
In this edition of the GW/JDD Translational Research Lecture Series, Chief of Pediatric Dermatology at the University of Cinncinatti and GW/Children’s National native Dr. Kalyani Marathe highlights the delicate and engendering approach to lichen sclerosus and reviews novel research that scratches beneath the surface of this pathophysiologically elusive, pruritic, disabling and deforming condition.
Dr. Jenny Kim will review skin’s important role as an immune organ and what happens when dysregulation occurs.
Presenter: Jenny Kim, MD, PhD is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and Chief of Dermatology at the Greater Los Angeles Healthcare System Veterans Affairs.
Special thanks to Ortho Dermatologics, Lilly, and Novartis for their support and exhibition at this event.
Dr. Sarah Aaron will review emerging research on squamous cell carcinoma (SCC) in transplant and non-transplant patients. She will also discuss how her studies of immunosuppressed patients have helped her treat the immunocompetent patient with SCC.
Presenter: Sarah Aaron, MD, PhD is a dermatologic surgeon who specializes in Mohs micrographic surgery. She is an Associate Professor of Dermatology and the Associate Director of Dermatologic Surgery and Laser Center at the University of California, San Francisco.
Special thanks to Ortho Dermatologics, Sanofi Regeneron, and AbbVie for their support and exhibition at this event.
Ginette A. Okoye MD, Professor and Chair of the Department of Dermatology at Howard University, walks us through her research on hidradenitis suppurativa, the pathogenesis of HS, and how studies contribute to our understanding and management of the disease. Dr. Okoye will also discuss how clinicians can incorporate research into their careers and share a few treatment pearls for HS.
Presenter: Ginette A. Okoye, MD is a Professor of Dermatology, Chair of the Department of Dermatology, at Howard University College of Medicine in Washington, DC.
Special thanks to Ortho Dermatologics, Sanofi and Regeneron for their support and exhibition at this event.
Dr. Benjamin Chong, Associate Professor of Dermatology in the Department of Dermatology at UT Southwestern Medical Center , sheds light (well hopefully not too much) on evidenced based expectations and management strategies for cutaneous lupus erythematosus.
Presenter:Benjamin Chong, M.D., is an Associate Professor in the Department of Dermatology at UT Southwestern Medical Center and holds the Anita C. Gilliam, M.D., Ph.D., Professorship in Dermatology. Dr. Chong is Director of the UT Southwestern Connective Tissue Disease Clinic and Medical Director of the Parkland Health and Hospital System Dermatology Clinic. He specializes in general dermatology and has expertise in cutaneous lupus erythematosus, dermatomyositis, and sarcoidosis.
Special thanks to
John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS explores emerging therapies in vitiligo.
Presenter: John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS
Special thanks to Ortho Dermatologics and Dermira for their support and exhibition at this event.
Should we be checking labs on our isotretinoin patients monthly? Will all patients on terbinafine develop hepatic failure? Can we find medications our patients can actually afford and work?
Go on a whirlwind tour of traditional clinical approaches which may not be more anecdote than science, highlighting the value of evidenced based medicine.
Presenter: Joslyn Kirby, MD, MS, Med, Associate Professor of Dermatology at Penn State College of Medicine
Thank you to Sun Pharma, Sanofi, Almirall, Regeneron, Lilly, AbbVie, UCB, and Mayne Pharma for their support and/or exhibition at this event.
An incredible investigative journey, from cell to mouse to human, to elucidate the pathophysiology of alopecia areata and develop both biomarkers for disease activity and treatment success, as well as targeted therapies to overcome this often recalcitrant and disabling disease.
Presenter: Angela Christiano, PhD, the Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics and Development at Columbia University
Thank you to Ortho Dermatologics, for their support of and exhibition at this event.
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
